Geron reported $57.48M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Amgen USD 10.1B 1.48B Jun/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Cytokinetics USD 28.6M 9.25M Jun/2026
Exelixis USD 628.69M 17.89M Jun/2026
Genmab DKK 1.06B 36M Dec/2025
Geron USD 57.48M 5.64M Jun/2026
Gilead Sciences USD 7.8B 800M Jun/2026
Incyte USD 1.67B 400M Jun/2026
MacroGenics USD 20.8M 20.43M Mar/2026
Novartis USD 14.41B 1.3B Jun/2026
Novavax USD 147.14M 76.69M Dec/2025